Evaluating the Efficacy of Enzalutamide and the Development of Resistance in a Preclinical Mouse Model of Type-I Endometrial Carcinoma

doi 10.1101/2019.12.06.868182
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cold Spring Harbor Laboratory

Related search

Evaluating Preclinical Efficacy

Science Translational Medicine
Medicine
2011English

Type I Endometrial Cancer After Chemoradiation Therapy for Carcinoma of the Cervix: A Case Report

Open Journal of Obstetrics and Gynecology
2011English

Efficacy of Recombinant Adenovirus as Vector for Allergen Gene Therapy in a Mouse Model of Type I Allergy

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2002English

Isolation and Evaluation of Anticancer Efficacy of Stigmasterol in a Mouse Model of DMBA-induced Skin Carcinoma

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2015English

Efficacy of Microwave Ablation for the Treatment of Endometrial Carcinoma: A Report of 3�cases

Oncology Letters
Cancer ResearchOncology
2016English

Use of Standardized SCID-hu Thy/Liv Mouse Model for Preclinical Efficacy Testing of Anti-Human Immunodeficiency Virus Type 1 Compounds.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1996English

Development and Characterization of a Preclinical Model for the Evaluation of CD205-Mediated Antigen Delivery Therapeutics in Type 1 Diabetes

ImmunoHorizons
2019English

Development of Xenograft Oral Squamous Cell Carcinoma Mouse Model

Yeditepe Dental Journal
2019English

Canagliflozin, an SGLT2 Inhibitor, Attenuates the Development of Hepatocellular Carcinoma in a Mouse Model of Human NASH

Scientific Reports
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy